Aprila Tablet

Aprmielast Introduction

Aprmielast is a prescription oral medication used to treat psoriatic arthritis and moderate to severe plaque psoriasis. It is an inhibitor of phosphodiesterase 4 (PDE4), an enzyme which plays a role in inflammation and immune response. Aprmielast is available in tablet form and is taken once a day.

Uses For

Aprmielast is indicated for the treatment of moderate to severe plaque psoriasis in adults and for the treatment of adults with active psoriatic arthritis. Aprmielast is not indicated for the treatment of other forms of arthritis.

Brand Name	Aprila
Type	Tablet
Weight	30 mg
Generic	Apremilast
Manufacturer	Drug International Ltd.
Available in	English বাংলা

Mechanism of Action

Aprmielast works by inhibiting the activity of the enzyme phosphodiesterase 4 (PDE4), which is involved inflammation. By blocking PDE4 activity, Aprmielast helps to reduce inflammation and reduce the symptoms associated with plaque psoriasis and psoriatic arthritis.

How Long Does it Take to Work?

The effect of Aprmielast can be seen within 4 to 6 weeks of treatment. Maximum effectiveness may not be seen until 12 weeks or longer. May take up to 16 weeks or longer to achieve maximum benefit.

Absorption

Aprmielast is rapidly absorbed after oral dosing. Peak concentrations are generally reached 2-3 hours after administration.

Route of Elimination

Aprmielast is eliminated from the body via renal excretion. About 65% of the absorbed dose is excreted unchanged in the urine.

Dosage

The recommended initial dosage titration of Apremilast from Day 1 to Day 5 is shown below. Following the 5-day titration, the recommended maintenance dosage is 30 mg twice daily taken orally starting on Day 6. This titration is intended to reduce the gastrointestinal symptoms associated with initial therapy. Apremilast can be administered without regard to meals.

Day 1: 10 mg in morning
Day 2: 10 mg in morning and 10 mg in evening
Day 3: 10 mg in morning and 20 mg in evening
Day 4: 20 mg in morning and 20 mg in evening
Day 5: 20 mg in morning and 30 mg in evening
Day 6: 30 mg twice daily

Dosage adjustment in patients with severe renal impairment. Apremilast dosage should be reduced to 30 mg once daily in patients with severe renal impairment. For initial dosage titration, it is recommended that Apremilast be titrated using only the morning schedule and the evening doses be skipped.

The recommended dosage of Aprmielast is 30 mg taken twice daily. This dosage can be increased to 60 mg twice daily if needed. Aprmielast should be taken with food in order to reduce the chance of stomach upset or diarrhea.

Administration

Aprmielast tablets should be swallowed whole with a glass of water. They should not be chewed, crushed, or broken. It is important to take Aprmielast exactly as directed by your healthcare provider.

Side Effects

Some common side effects of Aprmielast may include nausea, headache, diarrhea, abdominal pain, and fatigue. More serious side effects may include depression and suicidal thoughts.

Toxicity

Aprmielast has not been found to be toxic in clinical trials. However, patients should be monitored for serious side effects such as depression and suicidal ideation.

Precautions

Aprmielast should be used with caution in patients with a history of depression or other mental health conditions. It is important to discuss any concerns with your doctor before starting Aprmielast.

Interactions

Aprmielast may interact with certain prescription or over-the-counter medications, so it is important to discuss any potential drug interactions with your doctor before using Aprmielast.

Disease Interactions

Aprmielast may interact with certain diseases, such as depression or other mental health conditions. It is important to discuss any existing medical conditions with your doctor before using Aprmielast.

Drug Interactions

Aprmielast may interact with certain drugs. Be sure to tell your doctor about any other medications you may be taking before using Aprmielast.

Food Interactions

Foods that contain high-fat content may decrease the amount of Aprmielast that is absorbed. It is therefore recommended to avoid high-fat foods such as French fries when taking Aprmielast.

Pregnancy Use

Aprmielast has not been studied in pregnant women and therefore is not recommended for use in pregnant women. Women should speak to their doctor before taking Aprmielast if they are pregnant or planning to become pregnant.

Lactation Use

It is not known if Aprmielast is excreted in breast milk. Therefore, Aprmielast should not be used while breastfeeding.

Acute Overdose

If an overdose of Aprmielast is suspected, contact the Poison Control Center at 1-800-222-1222. Symptoms of overdose may include nausea, vomiting, abdominal pain, and diarrhea.

Contraindication

Aprmielast is contraindicated in patients with a known hypersensitivity to the drug, as well as those with severe liver impairment.

Use Directions

Aprmielast should be taken exactly as prescribed by your healthcare provider. It is important to take Aprmielast with food in order to reduce the chance of stomach upset or diarrhea.